PEDIARIX: clinical trials

Expert Rev Vaccines. 2005 Apr;4(2):139-45. doi: 10.1586/14760584.4.2.139.

Abstract

PEDIARIX is the first pentavalent combination vaccine licensed for use in infants in the USA. This vaccine is indicated for the prevention of diphtheria, tetanus, pertussis, hepatitis B and poliovirus. This article reviews the available data regarding the vaccine's immunogenicity and safety.

Publication types

  • Review

MeSH terms

  • Clinical Trials as Topic*
  • Diphtheria-Tetanus-Pertussis Vaccine
  • Hepatitis B Vaccines
  • Humans
  • Infant
  • Poliovirus Vaccine, Inactivated
  • Vaccines, Combined / administration & dosage*
  • Vaccines, Combined / adverse effects
  • Vaccines, Combined / immunology*

Substances

  • Diphtheria-Tetanus-Pertussis Vaccine
  • Hepatitis B Vaccines
  • PEDIARIX
  • Poliovirus Vaccine, Inactivated
  • Vaccines, Combined